New York State Common Retirement Fund
RNAC icon

New York State Common Retirement Fund’s Cartesian Therapeutics RNAC Stock Holding History

New York State Common Retirement Fund’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24K Hold
3,902
– – ﹤0.01% 2986
2025
Q4 		$28.1K Hold
3,902
– – ﹤0.01% 3037
2025
Q3 		$39.9K Hold
3,902
– – ﹤0.01% 3009
2025
Q2 		$40.5K Hold
3,902
– – ﹤0.01% 2996
2025
Q1 		$51.4K Hold
3,902
– – ﹤0.01% 2762
2024
Q4 		$69.9K Sell
3,902
-1,200
-24% -$24.3K ﹤0.01% 2740
2024
Q3 		$82.2K Hold
5,102
– – ﹤0.01% 2682
2024
Q2 		$138K Buy
5,102
+3,598
+239% +$85.9K ﹤0.01% 2591
2024
Q1 		$29.3K Hold
1,504
– – ﹤0.01% 3095
2023
Q4 		$31.1K Sell
1,504
-5
-0.3% -$149 ﹤0.01% 3097
2023
Q3 		$48K Sell
1,509
-1,318
-47% -$44K ﹤0.01% 3034
2023
Q2 		$95K Buy
+2,827
New +$101K ﹤0.01% 2893
2022
Q3 		– Sell
-30
Closed -$1K – 3421
2022
Q2 		$1K Sell
30
-1,697
-98% -$50.3K ﹤0.01% 3397
2022
Q1 		$64K Buy
1,727
+4
+0.2% +$250 ﹤0.01% 3119
2021
Q4 		$168K Sell
1,723
-7
-0.4% -$753 ﹤0.01% 2933
2021
Q3 		$216K Sell
1,730
-839
-33% -$101K ﹤0.01% 2881
2021
Q2 		$322K Buy
2,569
+1,215
+90% +$145K ﹤0.01% 2813
2021
Q1 		$184K Buy
1,354
+411
+44% +$51K ﹤0.01% 2868
2020
Q4 		$86K Sell
943
-1,124
-54% -$97.5K ﹤0.01% 3089
2020
Q3 		$154K Hold
2,067
– – ﹤0.01% 2760
2020
Q2 		$176K Buy
+2,067
New +$187K ﹤0.01% 2700
2019
Q2 		– Sell
-173
Closed -$12K – 3287
2019
Q1 		$12K Hold
173
– – ﹤0.01% 3146
2018
Q4 		$14K Sell
173
-560
-76% -$128K ﹤0.01% 3168
2018
Q3 		$342K Hold
733
– – ﹤0.01% 2588
2018
Q2 		$292K Buy
733
+273
+59% +$96.9K ﹤0.01% 2696
2018
Q1 		$141K Hold
460
– – ﹤0.01% 2865
2017
Q4 		$135K Buy
460
+43
+10% +$18.8K ﹤0.01% 2909
2017
Q3 		$228K Hold
417
– – ﹤0.01% 2712
2017
Q2 		$248K Buy
417
+270
+184% +$119K ﹤0.01% 2738
2017
Q1 		$63K Hold
147
– – ﹤0.01% 3039
2016
Q4 		$75K Buy
+147
New +$85.9K ﹤0.01% 3011

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund's RNAC Position: Q1 2026 in Review

New York State Common Retirement Fund held its Cartesian Therapeutics (RNAC) position steady in Q1 2026 at 3,902 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #2986.

New York State Common Retirement Fund first reported a position in RNAC in Q4 2016 and has held it in 31 quarters since. The position peaked at $342K in Q3 2018. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

  • New York State Common Retirement Fund held 3,902 shares of Cartesian Therapeutics worth $24K as of Q1 2026.
  • New York State Common Retirement Fund left its Cartesian Therapeutics share count unchanged in Q1 2026.
  • Cartesian Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2986 holding.
  • New York State Common Retirement Fund first reported a position in Cartesian Therapeutics in Q4 2016 and has held it in 31 quarters since.
  • New York State Common Retirement Fund's Cartesian Therapeutics position peaked at $342K in Q3 2018.
  • 83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.